tert-Butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate

Catalog No. :
ACCPTO803
CAS No. :
1704065-58-6
Molecular Formula :
C14H20IN3O2
Molecular Weight :
389.24

IUPAC Name:tert-butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate

tert-Butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$445.00Login to see priceInquiryInquiry
5g95%$1581.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate
Molecular FormulaC14H20IN3O2
Molecular Weight389.24
SMILESO=C(N1CCN(C2=NC=CC(I)=C2)CC1)OC(C)(C)C
InChI KeyDXUZSHQMPWBFFB-UHFFFAOYSA-N
Synonymtert-butyl 4-(4-iodopyridin-2-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(4-iodo-2-pyridinyl)-, 1,1-dimethylethyl ester
CAS No.1704065-58-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCPTO803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVZEK845 route compound structure diagram
    ACVZEK845100523-96-4 In Stock
  2. Plus
  3. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  4. Then
  5. ACCPTO803 route product structure diagram
    ACCPTO8031704065-58-6
Inquiry

2. ACCPTO803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACIUXW506 route compound structure diagram
    ACIUXW506153034-86-7 In Stock
  4. Then
  5. ACCPTO803 route product structure diagram
    ACCPTO8031704065-58-6
Inquiry

Comments (0)